Matches in DBpedia 2016-04 for { ?s ?p "Henri Boris Kagan (born 15 December 1930) is currently an Emeritus Professor at the Université Paris-Sud in France. He is widely recognized as a pioneer in the field of asymmetric catalysis. His discoveries have had far-reaching impacts on the pharmaceutical industry.He graduated from the Sorbonne and École nationale supérieure de chimie de Paris and carried out his PhD under J. Jacques at the Collège de France. Subsequently he was a research associate with A. Horeau. He then moved to Université Paris-Sud, Orsay where he is emeritus Professor. A landmark in his research was the development of C2-symmetric ligands, e.g., DIOP for asymmetric catalysis. This discovery led to the discovery of many related ligands that support catalysts used in a variety of practical applications."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Henri_B._Kagan abstract "Henri Boris Kagan (born 15 December 1930) is currently an Emeritus Professor at the Université Paris-Sud in France. He is widely recognized as a pioneer in the field of asymmetric catalysis. His discoveries have had far-reaching impacts on the pharmaceutical industry.He graduated from the Sorbonne and École nationale supérieure de chimie de Paris and carried out his PhD under J. Jacques at the Collège de France. Subsequently he was a research associate with A. Horeau. He then moved to Université Paris-Sud, Orsay where he is emeritus Professor. A landmark in his research was the development of C2-symmetric ligands, e.g., DIOP for asymmetric catalysis. This discovery led to the discovery of many related ligands that support catalysts used in a variety of practical applications.".
- Q354979 abstract "Henri Boris Kagan (born 15 December 1930) is currently an Emeritus Professor at the Université Paris-Sud in France. He is widely recognized as a pioneer in the field of asymmetric catalysis. His discoveries have had far-reaching impacts on the pharmaceutical industry.He graduated from the Sorbonne and École nationale supérieure de chimie de Paris and carried out his PhD under J. Jacques at the Collège de France. Subsequently he was a research associate with A. Horeau. He then moved to Université Paris-Sud, Orsay where he is emeritus Professor. A landmark in his research was the development of C2-symmetric ligands, e.g., DIOP for asymmetric catalysis. This discovery led to the discovery of many related ligands that support catalysts used in a variety of practical applications.".